All Cycles | |||||||
---|---|---|---|---|---|---|---|
Name | NC/NA | 1 | 2 | 3 | 4 | 5 | All grades |
Fatigue | 36% | 52% | 12% | 0% | 0% | 0% | 64% |
Alopecia | 44% | 48% | 8% | 0% | 0% | 0% | 56% |
Anemia | 48% | 12% | 24% | 16% | 0% | 0% | 52% |
Nausea | 60% | 40% | 0% | 0% | 0% | 0% | 40% |
Pharyngeal mucositis | 64% | 24% | 8% | 4% | 0% | 0% | 36% |
Constipation | 72% | 28% | 0% | 0% | 0% | 0% | 28% |
Platelet count decreased | 72% | 16% | 12% | 0% | 0% | 0% | 28% |
Vomiting | 72% | 28% | 0% | 0% | 0% | 0% | 28% |
Neutrophil count decreased | 80% | 0% | 8% | 12% | 0% | 0% | 20% |
White blood cell decreased | 80% | 4% | 12% | 4% | 0% | 0% | 20% |
Somnolence | 80% | 12% | 8% | 0% | 0% | 0% | 20% |
Diarrhea | 84% | 12% | 0% | 4% | 0% | 0% | 16% |
General disorders and administration site conditions ‐ Other, specify | 84% | 16% | 0% | 0% | 0% | 0% | 16% |
Anorexia | 88% | 12% | 0% | 0% | 0% | 0% | 12% |
Alanine aminotransferase increased | 92% | 8% | 0% | 0% | 0% | 0% | 8% |
Aspartate aminotransferase increased | 96% | 4% | 0% | 0% | 0% | 0% | 4% |
Lung infection | 92% | 0% | 0% | 8% | 0% | 0% | 8% |
Confusion | 96% | 4% | 0% | 0% | 0% | 0% | 4% |
Gastrointestinal disorders ‐ Other, specify | 96% | 0% | 4% | 0% | 0% | 0% | 4% |
Generalized muscle weakness | 96% | 0% | 4% | 0% | 0% | 0% | 4% |
Headache | 96% | 4% | 0% | 0% | 0% | 0% | 4% |
Hypokalemia | 96% | 4% | 0% | 0% | 0% | 0% | 4% |
Oral pain | 96% | 4% | 0% | 0% | 0% | 0% | 4% |
Hallucinations | 96% | 4% | 0% | 0% | 0% | 0% | 4% |
Skin and subcutaneous tissue disorders ‐ Other, specify | 96% | 4% | 0% | 0% | 0% | 0% | 4% |
Hypersomnia | 96% | 0% | 4% | 0% | 0% | 0% | 4% |
Adverse Events Legend | |||||||
Abbreviation: NC/NA, no change from baseline/no adverse event. |